Six years since COVID-19 was declared a public health emergency of international concern, science has never been more dynamic. Innovation has accelerated, sequencing technologies are more accessible, artificial intelligence is transforming biomedical research, and the World Health Organization Pandemic Agreement has laid the foundations for a long-awaited multilateral framework.
Yet one uncomfortable truth remains: the world still cannot guarantee that safe and effective diagnostics, treatments, and vaccines will be available and equitably deployed within the first 100 days of a new pandemic threat.
In 2021, the Group of Seven leading economies established the 100 Days Mission to close this gap, recognizing that the first three months of an outbreak determine its global trajectory — and that failure to act at speed could cost millions of lives. Later that same year, the Group of 20 major economies endorsed the mission.